Role of Positron Emission Tomography in the Evaluation of Response to Sorafenib in Advanced Hepatocellular Carcinoma

This study has been completed.
Sponsor:
Collaborators:
Fondo de Investigacion Sanitaria
Carlos III Health Institute
Spanish National Health System
Aragon Health Science Institute
Information provided by:
Hospital Miguel Servet
ClinicalTrials.gov Identifier:
NCT01157013
First received: July 2, 2010
Last updated: NA
Last verified: July 2010
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2010
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)